Could changes to ADHD meds be a game-changer or a risk?

Pharmac is now funding a new medicine and has removed renewal criteria for ADHD treatments.  Advocates are welcoming the move – saying it’s a game-changer that will save the health system tens of millions of dollars. But, there are warnings it could lead to over-diagnosing and over-prescribing. Today on The Front Page, co-founder of DivergenThinking and registered psychologist, Anton Ashcroft joins us to discuss. Follow The Front Page on iHeartRadio, Apple Podcasts, Spotify or wherever you get your podcasts. You can read more about this and other stories in the New Zealand Herald, online at nzherald.co.nz, or tune in to news bulletins across the NZME network. Host: Chelsea DanielsSound Engineer/Producer: Richard MartinProducer: Ethan SillsSee omnystudio.com/listener for privacy information.

Om Podcasten

Keeping up to date with the news just became a little easier. Available every weekday at 5am, tune in as Chelsea Daniels chats with the journalists and newsmakers, going behind the headlines to break down what you need to know on the biggest stories of the day.